Key result
PCOS is linked to ~100% higher UDFF in women with obesity versus obesity alone.
Why the study?
To investigate the feasibility of ultrasound-derived fat fraction as an evaluation index for obese women with polycystic ovary syndrome.
Does ultrasound-derived fat fraction (UDFF) correlate with metabolic and hormonal severity in obese women with polycystic ovary syndrome (PCOS)?
Population
103 women with PCOS and obesity and 108 obese women without PCOS
Comparison
Women with PCOS and obesity vs obese women without PCOS
Design
Case-control study
Authors
Loading...
Supports UDFF for non-invasive metabolic severity assessment in obese PCOS; extends evidence but remains hypothesis-generating pending validation.
Cohort (n=211)
No
Does ultrasound-derived fat fraction (UDFF) correlate with metabolic and hormonal severity in obese women with polycystic ovary syndrome (PCOS)?
Absolute Event Rate: 10% vs 5%
p-value: p=<0.001
Hepatic ultrasound-derived fat fraction (UDFF) combined with other ultrasound and clinical markers provides a strong non-invasive diagnostic model for assessing the severity of metabolic and hormonal disorders in obese women with PCOS.
Meng et al. (2026) conducted a cohort in Polycystic Ovary Syndrome with Obesity (n=211). Ultrasound-derived fat fraction (UDFF) vs. Obese women without PCOS was evaluated on Comparison of ultrasound-derived fat fraction values between women with PCOS and obesity and control group (p=<0.001). Ultrasound-derived fat fraction (UDFF) values were significantly higher in women with polycystic ovary syndrome and obesity (10%) compared to those without PCOS (5%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: